2nd Quarter - Report

ABBVIE, INC. for ABBVIE INC.

Firm
Client
Income
—
Expenses
$1,700,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R. 1430, Permanent CFC Look-Through Act; H.R. 415 & S. 198, Stop Corporate Inversions Act; S. 2786, Corporate Inverters Earnings Stripping Reform; S. 2895, Pay What You Owe Before You Go Act; H.R. 1809, No Federal Contracts for Corporate Deserters Act; H.R. 248, American Job Protection Act; S. 1946, Tax Relief Extention Act of 2015; Administrations Tax Reform and Budget Proposals; Senate and House Committee Tax Reform Proposals; H.R. 1, Tax Reform Act of 2014 (as introduced in the 113th Congress) H.R. 4900, H.R. 5278 & S. 2328, PROMESA; Puerto Rican Economy and Debt Relief Proposals (no bills introduced); Proposals to reform domestic and international tax structures (no bills introduced; Issues related to international tax reform including transitioning to a territorial tax system;

LobbyistCovered position, as disclosed
DANIEL BACHNER —
MICHAEL D BOYD —
JOHN P. FORD —
ANDREW KAPLAN —
STEPHEN SCANGO —
HEATHER STRAWN —

Contacted: Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); SENATE; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); State, Dept of (DOS)

Bills named: S. 2786 (114th), H.R. 4900 (114th), S. 2895 (114th), H.R. 1809 (114th), H.R. 415 (114th), H.R. 1430 (114th), S. 198 (114th), H.R. 1 (114th), H.R. 5278 (114th), S. 2328 (114th), H.R. 248 (114th), S. 1946 (114th)

Copyright/Patent/Trademark CPT

H.R. 406 & S. 1767, Combination Drug Development Incentive Act of 2015; S. 632, STRONG Patents Act of 2015; H.R. 9, Innovation Act; H.R. 160, Protect Medical Innovation Act of 2015; S. 2733, Venue Equity and Non-Uniformity Elimination Act of 2016; H.R. 971 & S. 1421, Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015; H.R. 5573 & S. 3094, Price Relief, Innovation, and Competition for Essential Drugs (PRICED) Act; S. 3056, CREATES Act of 2016; Proposals/Initatives related to international intellectual property protection; H.R. 1806, America COMPETES Reauthorization Act of 2015;

LobbyistCovered position, as disclosed
DANIEL BACHNER —
MICHAEL D BOYD —
JOHN P. FORD —
ANDREW KAPLAN —
HEATHER STRAWN —

Contacted: Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); SENATE; State, Dept of (DOS); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES

Bills named: S. 3056 (114th), H.R. 5573 (114th), S. 632 (114th), H.R. 9 (114th), S. 3094 (114th), S. 1421 (114th), S. 1767 (114th), H.R. 160 (114th), S. 2733 (114th), H.R. 971 (114th), H.R. 406 (114th), H.R. 1806 (114th)

Health Issues HCR

H.R. 6, 21st Century Cures Act; S. 2700, FDA and NIH Workforce Authorities Modernization Act; Discussions to clarify or reform the 340B program; Biologics Price Competition and Innovation Act; Public Law 111-148, The Patient Protection and Affordable Care Act; H.R. 2228 & S.122, Safe and Affordable Drugs from Canada Act of 2015; Proposals to address prescription drug abuse; Implementation of The Prescription Drug User Fee Act (PDUFA); Implementation of The Biosimilars User Fee Act (BsUFA); H.R. 2570 & S. 1396, Value-Based Insurance Design Seniors Copayment Reduction Act of 2015; H.R. 3677 Opioid Abuse Prevention and Treatment Act of 2015; S. 524, Comprehensive Addiction and Recovery Act of 2016; H.R. 3012 & S. 2912, Trickett Wendler Right to Try Act of 2016; Expanded Access to (draft legislation);

LobbyistCovered position, as disclosed
DANIEL BACHNER —
MICHAEL D BOYD —
JOHN P. FORD —
ANDREW KAPLAN —
STEPHEN SCANGO —
HEATHER STRAWN —

Contacted: Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); SENATE; Medicare Payment Advisory Commission (MedPAC)

Bills named: S. 122 (114th), S. 1396 (114th), S. 2700 (114th), S. 524 (114th), H.R. 2570 (114th), H.R. 2228 (114th), H.R. 3012 (114th), H.R. 6 (114th), S. 2912 (114th), H.R. 3677 (114th)

Medicare/Medicaid MMM

Policies to enhance patient access to medicines in Medicaid; Policies to enhance patient access to medicines in Medicare; H.R. 2298, Medicare Patient Safety and Drug Abuse Prevention Act; H.R. 1190 & S. 141, Protecting Seniors' Access to Medicare Act of 2015; H.R. 2925, Strengthening Medicare Anti-Fraud Measures Act; * H.R. 1102 & S. 117, Medicare Prescription Drug Price Negotiation Act; * H.R. 3261 & S. 1884, Medicare Prescription Drug Savings and Choice Act of 2015; S. 1913, Stopping Medication Abuse and Protecting Seniors Act; H.R. 5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models; Medicare payment proposals;

LobbyistCovered position, as disclosed
DANIEL BACHNER —
MICHAEL D BOYD —
JOHN P. FORD —
ANDREW KAPLAN —
STEPHEN SCANGO —
HEATHER STRAWN —

Contacted: SENATE; State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Medicare Payment Advisory Commission (MedPAC); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 117 (114th), S. 1913 (114th), H.R. 2298 (114th), H.R. 1190 (114th), H.R. 3261 (114th), S. 141 (114th), S. 1884 (114th), H.R. 1102 (114th), H.R. 2925 (114th), H.R. 5122 (114th)

Trade (domestic/foreign) TRD

Trans-Atlantic Trade and Investment Partnership; Trans-Pacific Partnership Agreement; Trade Promotion Authority; Colombia OECD Accession; Middle East Priorities Briefing; Japanese Consumption Tax;

LobbyistCovered position, as disclosed
DANIEL BACHNER —
MICHAEL D BOYD —
JOHN P. FORD —
ANDREW KAPLAN —
STEPHEN SCANGO —
HEATHER STRAWN —

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Medicare Payment Advisory Commission (MedPAC); Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); SENATE; U.S. Trade Representative (USTR)

Budget/Appropriations BUD

H.R. 4974 & S. 2806, Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2017; S. 2804, Energy and Water Development and Related Agencies Appropriations Act, 2017 (and related House bill not yet introduced); P.L. 114-113, Consolidated Appropriations Act, 2016 (H.R. 2029); Other Labor, Health and Human Services Appropriations (No Bills Introduced); Potential Amendments to Appropriations Bills (not introduced);

LobbyistCovered position, as disclosed
DANIEL BACHNER —
MICHAEL D BOYD —
JOHN P. FORD —
ANDREW KAPLAN —
HEATHER STRAWN —

Contacted: State, Dept of (DOS); Medicare Payment Advisory Commission (MedPAC); Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC)

Bills named: S. 2806 (114th), S. 2804 (114th), H.R. 2029 (114th), H.R. 4974 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.